Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases

E-ISSN： 1873-4286|23|7|1077-1097

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.7, 2017-04, pp. : 1077-1097

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Danshen (Salvia miltiorrhiza Bunge): A Prospective Healing Sage for Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 23, Iss. 34, 2018-01 ,pp. : 5125-5135

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical and Biomedical Analysis of Terpene Constituents in Salvia miltiorrhiza

Current Pharmaceutical Analysis, Vol. 4, Iss. 4, 2008-11 ,pp. : 249-257

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka Shimokawa Hiroaki

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite

Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 24, Iss. 2, 2018-04 ,pp. : 239-258

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases

Current Drug Targets, Vol. 13, Iss. 9, 2012-08 ,pp. : 1215-1221

Bentham Science Publishers

Access to resources Recommend Favorite